A number of late stage failures from British biotech firms have left a looming question mark over the future of …
UK biotech Renovo is planning to reduce its headcount by over a third after a takeover approach from an unnamed …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

